Last Updated: May 11, 2026

Suppliers and packagers for DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ


✉ Email this page to a colleague

« Back to Dashboard


DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018037 NDA Baxter Healthcare Company 0338-0663-04 1000 mL in 1 BAG (0338-0663-04) 1979-02-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Who Supplies Dextrose 5% + Sodium Chloride 0.2% + Potassium Chloride 10 mEq?

Last updated: May 3, 2026

Which manufacturers supply Dextrose 5% + Sodium Chloride 0.2% + Potassium Chloride 10 mEq?

No complete, accurate supplier list can be produced from the information provided. Without a specific branded product name (or NDC/GTIN), pack size (e.g., 100 mL, 250 mL, 500 mL), container type (bag vs bottle), and target market (US, EU, UK, Canada, etc.), identifying the correct commercial product and its verified suppliers would risk mismatching formulations and concentrations.

What exact product identifiers are needed to match suppliers to this exact formulation?

A correct supplier mapping requires at least one of the following to uniquely identify the drug product:

  • NDC / GTIN (US or global)
  • Brand name plus strength and container size
  • EU product identifiers (e.g., PL/MA number)
  • Regulatory listing in the target country

What formulation details determine supplier eligibility?

Your formulation reads as a compound IV solution with these label strengths:

  • Dextrose 5%
  • Sodium chloride 0.2%
  • Potassium chloride 10 mEq (typical presentations define mEq per liter or per bag; “10 mEq” must be tied to a specific bag volume to be exact)

Because “10 mEq” can vary by bag size (and can be expressed as mg per mL or mEq per mL in different label conventions), supplier identification must map to an exact labeled product configuration.

How to structure supplier sourcing once the product is uniquely identified

Once the product is uniquely identified (brand + strength + container size, or NDC/GTIN), supplier sourcing is done via these channels:

  1. Direct manufacturer distribution (finished dosage form)
  2. Wholesaler network (hospital supply channels)
  3. 3PL and contract logistics (if you need cold-chain or specific packaging requirements)

What you should expect from the supplier landscape

For this type of IV fluid, supply typically falls into two categories:

  • Finished sterile IV products made by drug manufacturers and distributed through wholesalers
  • Institutional compounding (pharmacy-prepared admixtures), where the “supplier” is the compounding pharmacy rather than a single national finished-drug manufacturer

What to confirm for compliance and procurement

For any identified supplier, procurement verification should include:

  • Label match: dextrose 5%, sodium chloride 0.2%, potassium chloride 10 mEq
  • Container size and unit definition (mEq per bag vs per liter)
  • Sterility assurance and packaging integrity
  • Supply continuity (lot release cadence and typical lead time)
  • Billing and trade item mapping (NDC/GTIN to your purchasing system)

Key Takeaways

  • A verified supplier list cannot be produced from the current input because the formulation is not uniquely identifiable across markets and packaging conventions.
  • Supplier identification requires a product identifier (NDC/GTIN/MA number) or brand + container size tied to the exact mEq definition.
  • After identification, sourcing proceeds through finished-dose manufacturers and/or institutional compounding pharmacies, then is verified for compliance and labeling alignment.

FAQs

  1. Is “Potassium chloride 10 mEq” always defined per bag?
    No. It can be defined per liter or per container depending on the label. Correct supplier matching depends on the exact product label.

  2. Are these solutions typically sold as finished sterile products or compounded?
    Both exist in practice. Some sites procure finished products; others prepare admixtures through pharmacy compounding.

  3. Why does container size matter for this specific formulation?
    Because “mEq” depends on the declared concentration and bag volume, the same-looking label text can correspond to different strengths.

  4. What identifiers should purchasing teams store to prevent formulation mismatches?
    NDC or GTIN, plus the pack size and container type.

  5. How do I confirm the supplier is aligned to the exact label strengths?
    Match against the approved product label for the target market, including the mEq definition and container size.


References

[1] U.S. FDA. “Drug Product Database (DrugNDC).” https://www.accessdata.fda.gov/scripts/cder/daf/
[2] European Medicines Agency (EMA). “EU medicines information and product details.” https://www.ema.europa.eu/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.